The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development.
View/ Open
Date
2016-10-13ICR Author
Author
Kerkmeijer, LGW
Fuller, CD
Verkooijen, HM
Verheij, M
Choudhury, A
Harrington, KJ
Schultz, C
Sahgal, A
Frank, SJ
Goldwein, J
Brown, KJ
Minsky, BD
van Vulpen, M
MR-Linac Consortium Clinical Steering Committee,
Type
Journal Article
Metadata
Show full item recordAbstract
An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.
Collections
Subject
MR-Linac Consortium Clinical Steering Committee
Research team
Targeted Therapy
Language
eng
Date accepted
2016-09-28
License start date
2016-01
Citation
Frontiers in oncology, 2016, 6 pp. 215 - ?
Publisher
FRONTIERS MEDIA SA